One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Asia Digital Advertising in Pharma Market

製薬市場におけるアジアのデジタル広告市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2028年


[ 英語タイトル ] Asia Digital Advertising in Pharma Market Outlook 2030


Product Code : Research NesterHC00116089
Survey : Research Nester
Publish On : November, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Asia
Report format : PDF
Sales price option (consumption tax not included)
BBDO, AMICULUM Limited, WebHopers Infotech PVT. LTD., The Ogilvy Group, WebFX, Amura Marketing Technologies, Medibrandox

[Report Description]

Asia Digital Advertising in Pharma Market Analysis 2015-2030

Digital advertising is a promotional activity that delivers the target audience through digital platforms, including social media, search engines, websites, and others. As the healthcare industry is growing online on a large scale, thus, digital advertising in the pharmaceutical sector is one of the easiest ways to meet prospects and advertise pharmaceutical products and services. The Asia digital advertising in pharma market is anticipated to grow with a CAGR of 13.8% over the forecast period, i.e., 2021 – 2030. Factors such as the growing awareness for digital advertising amongst pharmaceutical companies, backed by the numerous benefits associate with the advertising method, such as cost-effectiveness and scalability, along with the increasing pharmaceutical industry in Asia are anticipated to drive the growth of the market in the coming years. The Asia digital advertising in pharma market is estimated to garner a revenue of around USD 22260 Million by the end of 2030, up from a revenue of close to USD 3630 Million in the year 2015.
The Asia digital advertising in pharma market is segmented by numerous segments, which include segmentation by ad format, product type, category, platform, and by country. By platform, the market is segmented into mobile, desktop, and other platforms. Amongst these, in the year 2015, the mobile segment generated a revenue of near to USD 2600 Million. The segment is further expected to cross USD 16590 Million by the end of 2030.
By country, the Asia digital advertising in pharma market is segmented into Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, Hong Kong, Taiwan, Japan, South Korea, Rest of Southeast Asia, and the Rest of Asia. Amongst these, by the end of 2030, the market in Japan is anticipated to hold the second-largest revenue of about USD 4940 Million. In the year 2015, the market in the region generated a revenue of around USD 880 Million.
Some of the prominent industry leaders in the Asia digital advertising in pharma market that are included in our report are BBDO, AMICULUM Limited, WebHopers Infotech PVT. LTD., The Ogilvy Group, WebFX, Amura Marketing Technologies, Medibrandox, and others.

Asia Digital Advertising in Pharma Market TOC

1. Market Definition and Research Methodology
1.1. Market Definition and Segmentation
1.2. Assumptions and Acronyms
1.3. Research Objective
1.4. Research Methodology
2. Analyst Review
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Challenges
4.3. Trends
4.4. Opportunities
5. Industry Analysis
5.1. Regulatory and Standard Landscape
5.2. Industry risk analysis
5.3. Consumer Behavior Analysis
6. Impact of COVID-19 on the Asia Digital Advertising in Pharma Market
7. Spending Analysis on Pharma Medical Sales Representative
8. Spending Analysis on Pharma Product Advertising
9. Spending Analysis on Product Sales Incentives and Programs
10. Analysis on Pharma Companies
11. Competitive Positioning
12. Comparative Feature Analysis
13. Competitive Landscape
14. Asia Digital Advertising in Pharma Market
14.1. Market Overview – Market size (2015-2030)
14.2. Market Segmentation by:
14.2.1. Ad Format
14.2.1.1. Social Media Ads, 2015-2030 (in USD Million)
14.2.1.2. Native Ads, 2015-2030 (in USD Million)
14.2.1.3. Search Engine Ads, 2015-2030 (in USD Million)
14.2.1.4. Display Ads, 2015-2030 (in USD Million)
14.2.1.5. Video Advertising, 2015-2030 (in USD Million)
14.2.1.6. Mobile Advertising, 2015-2030 (in USD Million)
14.2.1.7. Banner Ads, 2015-2030 (in USD Million)
14.2.1.8. Other Ads, 2015-2030 (in USD Million)
14.2.2. Product Type
14.2.2.1. Patent Medicine, 2015-2030 (in USD Million)
14.2.2.2. Generic Medicine, 2015-2030 (in USD Million)
14.2.3. Category
14.2.3.1. Prescription Drugs, 2015-2030 (in USD Million)
14.2.3.2. OTC Drugs, 2015-2030 (in USD Million)
14.2.4. Platform
14.2.4.1. Mobile, 2015-2030 (in USD Million)
14.2.4.2. Desktop, 2015-2030 (in USD Million)
14.2.4.3. Other Platforms, 2015-2030 (in USD Million)
14.2.5. Country
14.2.5.1. Singapore
14.2.5.2. Indonesia
14.2.5.3. Thailand
14.2.5.4. Malaysia
14.2.5.5. Vietnam
14.2.5.6. Philippines
14.2.5.7. Hong Kong
14.2.5.8. Taiwan
14.2.5.9. Japan
14.2.5.10. South Korea
14.2.5.11. Rest of Southeast Asia
14.2.5.12. Rest of Asia
15. Singapore Digital Advertising in Pharma Market
15.1. Market Overview – Market size (2015-2030)
15.2. Market Segmentation by:
15.2.1. Ad Format
15.2.1.1. Social Media Ads, 2015-2030 (in USD Million)
15.2.1.2. Native Ads, 2015-2030 (in USD Million)
15.2.1.3. Search Engine Ads, 2015-2030 (in USD Million)
15.2.1.4. Display Ads, 2015-2030 (in USD Million)
15.2.1.5. Video Advertising, 2015-2030 (in USD Million)
15.2.1.6. Mobile Advertising, 2015-2030 (in USD Million)
15.2.1.7. Banner Ads, 2015-2030 (in USD Million)
15.2.1.8. Other Ads, 2015-2030 (in USD Million)
15.2.2. Product Type
15.2.2.1. Patent Medicine, 2015-2030 (in USD Million)
15.2.2.2. Generic Medicine, 2015-2030 (in USD Million)
15.2.3. Category
15.2.3.1. Prescription Drugs, 2015-2030 (in USD Million)
15.2.3.2. OTC Drugs, 2015-2030 (in USD Million)
15.2.4. Platform
15.2.4.1. Mobile, 2015-2030 (in USD Million)
15.2.4.2. Desktop, 2015-2030 (in USD Million)
15.2.4.3. Other Platforms, 2015-2030 (in USD Million)
16. Indonesia Digital Advertising in Pharma Market
16.1. Market Overview – Market size (2015-2030)
16.2. Market Segmentation by:
16.2.1. Ad Format
16.2.2. Product Type
16.2.3. Category
16.2.4. Platform
17. Thailand Digital Advertising in Pharma Market
17.1. Market Overview – Market size (2015-2030)
17.2. Market Segmentation by:
17.2.1. Ad Format
17.2.2. Product Type
17.2.3. Category
17.2.4. Platform
18. Malaysia Digital Advertising in Pharma Market
18.1. Market Overview – Market size (2015-2030)
18.2. Market Segmentation by:
18.2.1. Ad Format
18.2.2. Product Type
18.2.3. Category
18.2.4. Platform
19. Vietnam Digital Advertising in Pharma Market
19.1. Market Overview – Market size (2015-2030)
19.2. Market Segmentation by:
19.2.1. Ad Format
19.2.2. Product Type
19.2.3. Category
19.2.4. Platform
20. Philippines Digital Advertising in Pharma Market
20.1. Market Overview – Market size (2015-2030)
20.2. Market Segmentation by:
20.2.1. Ad Format
20.2.2. Product Type
20.2.3. Category
20.2.4. Platform
21. Hong Kong Digital Advertising in Pharma Market
21.1. Market Overview – Market size (2015-2030)
21.2. Market Segmentation by:
21.2.1. Ad Format
21.2.2. Product Type
21.2.3. Category
21.2.4. Platform
22. Taiwan Digital Advertising in Pharma Market
22.1. Market Overview – Market size (2015-2030)
22.2. Market Segmentation by:
22.2.1. Ad Format
22.2.2. Product Type
22.2.3. Category
22.2.4. Platform
23. Japan Digital Advertising in Pharma Market
23.1. Market Overview – Market size (2015-2030)
23.2. Market Segmentation by:
23.2.1. Ad Format
23.2.2. Product Type
23.2.3. Category
23.2.4. Platform
24. South Korea Digital Advertising in Pharma Market
24.1. Market Overview – Market size (2015-2030)
24.2. Market Segmentation by:
24.2.1. Ad Format
24.2.2. Product Type
24.2.3. Category
24.2.4. Platform
25. Rest of South East Asia Digital Advertising in Pharma Market
25.1. Market Overview – Market size (2015-2030)
25.2. Market Segmentation by:
25.2.1. Ad Format
25.2.2. Product Type
25.2.3. Category
25.2.4. Platform
26. Rest of Asia Digital Advertising in Pharma Market
26.1. Market Overview – Market size (2015-2030)
26.2. Market Segmentation by:
26.2.1. Ad Format
26.2.2. Product Type
26.2.3. Category
26.2.4. Platform

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+